Polyarteritis Nodosa Life Insurance (IUL & GUL) in 2026

Yes, You Can Get Life Insurance with Polyarteritis Nodosa

If you have been diagnosed with polyarteritis nodosa (PAN), you have probably wondered whether permanent life insurance is even an option. The short answer is yes. While this condition does affect how carriers evaluate your application, many of our clients with PAN have successfully secured both IUL and GUL policies. The key is understanding what underwriters look for and positioning your application to get the most favorable rating possible.

Polyarteritis nodosa is a vasculitis condition that causes inflammation in medium sized arteries, and it can affect multiple organ systems. Underwriters view it through the lens of disease severity, organ involvement, treatment response, and overall functional status. That said, a well managed case with stable labs and specialist follow up puts you in a much stronger position than you might expect. Wegener’s granulomatosis sits in the same vasculitis family, and our IUL and GUL options for wegener’s granulomatosis apply that underwriting lens to GPA specifically.

What Underwriters Actually Evaluate for Polyarteritis Nodosa

When we submit an application for a client with PAN, underwriters focus on a specific set of factors. Understanding these gives you a real advantage.

The primary concerns include your specific diagnosis and which organs or areas are involved, disease severity and how it impacts your daily functioning, current treatment protocols, and your response to those treatments. They also examine lab work closely, including inflammatory markers like ESR and CRP, along with any imaging findings.

Secondary factors matter too. These include whether you have other systemic involvement such as additional rheumatologic conditions, any history of depression or anxiety related to chronic pain, medication history (especially opioid use), and how frequently you need medical interventions or procedures.

What moves you toward a better classification is a mild condition with minimal functional impact, managing pain without opioids, stable disease with no progression on imaging, good functional status and activity levels, compliance with treatment plans, regular specialist follow up, and having no other significant comorbidities.

What pushes your rating higher includes severe functional limitations, multiple organ involvement, chronic opioid use (especially at higher doses), poor imaging results showing disease progression, and needing frequent interventions or recurring procedures.

How Table Ratings Work for IUL and GUL Policies

Here is something most people do not realize about life insurance pricing. Table ratings follow a predictable structure. Table 1 adds roughly 25% above standard rates. Table 2 adds about 50%. Table 4 doubles the standard cost. Table 6 adds 150%, and so on up through Table 10.

Let us put that into real numbers. On a $500,000 GUL policy for a 40 year old, a standard rate might run around $250 per month. A Table 2 rating could bring that to approximately $375 per month. A Table 4 might mean roughly $500 per month. Those are meaningful differences, which is exactly why getting the best possible rating matters so much.

For IUL policies, the math works similarly, though the cash value growth component can offset some of that cost over time through market indexed returns. That is one reason many clients with PAN find IUL appealing. The policy builds value even while carrying a table rating.

Polyarteritis Nodosa and GUL: Why Guaranteed Universal Life Deserves a Look

For clients with polyarteritis nodosa, GUL policies offer something uniquely valuable. A guaranteed universal life policy locks in a death benefit with guaranteed premiums that will not increase regardless of market performance. If your primary goal is ensuring your family has a permanent safety net, GUL removes the uncertainty from the equation.

Because GUL premiums are fixed, you know exactly what your table rated cost will be for the life of the policy. There are no surprises. For someone managing a chronic condition like PAN, that predictability can be worth a great deal.

Why an Independent Agency Makes the Biggest Difference

This is where things get really interesting for someone with polyarteritis nodosa. Different carriers can rate the exact same health profile two to four tables apart. One company might see your well managed PAN and assign a Table 4 rating, while another carrier, looking at the same medical records, assigns a Table 2. Over the life of a permanent policy, that gap can mean tens of thousands of dollars.

This is exactly why Insurance By Heroes exists. We were founded by a former first responder and military spouse, and every member of our team comes from a background in public service. That service first mindset means we treat every client’s application the way we would want our own family treated. We are also fully independent, which means we are not locked into pushing one carrier’s products. We shop your case across many different companies to find the one that views your specific situation most favorably.

That independent advantage is not a small thing. It is often the single biggest factor in what you actually end up paying.

Positioning Your Application for the Best Possible Outcome

Before you apply, gather your documentation. Carriers typically want recent imaging reports with radiologist interpretation, lab work including inflammatory markers, a current medication list, specialist evaluation records from your rheumatologist, and documentation of your treatment compliance and response.

Timing also matters enormously. If you have recently had a procedure or change in treatment, waiting until you have a stable track record of good results can move you one or two tables in the right direction. However, do not wait indefinitely. Getting older introduces its own rating factors, and the possibility of additional health developments means today’s application could actually be your strongest one.

One of the best things you can do is manage your condition without opioid pain medications if possible. Chronic opioid use, especially at doses above 90 MME, is a major red flag for underwriters. If you are controlling symptoms through biologics, anti inflammatory medications, physical therapy, or other conservative treatments, that works strongly in your favor.

Common Mistakes That Cost Real Money

When we work with clients who have polyarteritis nodosa, we frequently see avoidable errors that lead to worse ratings or even denials.

• Not specifying the exact diagnosis. Simply saying “arthritis” or “vasculitis” without clarifying PAN versus other conditions can trigger a more cautious underwriting approach. Be precise.
• Not knowing your current medication doses. Get exact dosing information before applying. Vague answers about medications make underwriters assume the worst.
• Forgetting to mention improvements. If your condition has stabilized or improved with treatment, that information needs to be front and center. Underwriters cannot give you credit for progress they do not know about.
• Skipping the specialist records. Descriptions of your condition from a primary care physician are not as persuasive as detailed evaluations from your rheumatologist. Specialist documentation carries significantly more weight.
• Applying through a captive agent who only represents one carrier. If that single carrier rates PAN harshly, you are stuck with an inflated premium or a decline, when another company might have offered a much better deal.

FAQ

How much more does life insurance cost with polyarteritis nodosa?

Most applicants with well managed PAN receive table ratings between Table 2 and Table 6, which means paying 50% to 150% above standard rates. On a $500,000 policy, that could mean an extra $125 to $375 per month depending on your age, overall health, and which carrier you use. Shopping across many carriers often saves two or more table ratings.

Can I get approved for IUL or GUL with polyarteritis nodosa?

Yes. Both indexed universal life and guaranteed universal life policies are available to most people with PAN. Approval at a table rating is the most common outcome rather than a decline. The severity of your condition, your treatment response, and which carrier reviews your application all play a role in your final offer.

Should I wait until my condition improves before applying?

If you recently started a new treatment or had a procedure, waiting six to twelve months for stable results can improve your rating. However, waiting too long introduces age related cost increases and the risk of new health developments. We generally recommend applying once you have a documented track record of stability with your current treatment.

What if I have been declined for life insurance because of polyarteritis nodosa?

A decline from one carrier does not mean every carrier will decline you. Each company has different underwriting guidelines for vasculitis conditions. We have placed coverage for clients who were previously declined elsewhere by identifying carriers with more favorable approaches to PAN. Reach out to our team for a free case review and we will identify your best options.

Related health conditions

A table rated approval is the common outcome for many chronic conditions, and the same IUL and GUL route applies to applicants with Myasthenia Gravis IUL and GUL life insurance, IUL and GUL life insurance with multiple sclerosis, Trigeminal Neuralgia IUL and GUL insurance and Sarcoidosis IUL and GUL insurance.